In this issue:
Gender differences in clinical presentation and illicit substance use during first episode psychosis
LAIs vs oral antipsychotics for the maintenance treatment of schizophrenia
Cognitive remediation effectiveness for cognition and functioning in schizophrenia
High frequency rTMS of dorsomedial prefrontal cortex in patients with schizophrenia
Risk of mortality and complications in patients with schizophrenia and diabetes mellitus
Clozapine treatment and risk of COVID-19 infection
Reduced functional connectivity of the hippocampus-midbrain-striatum network in schizophrenia
Chemokine MCP1 is associated with cognitive flexibility in schizophrenia
Co-occurrence of ASD and schizophrenia
Safety and tolerability of cariprazine for schizophrenia
Please login below to download this issue (PDF)